Enveric Biosciences ENVB
NASDAQ ENVB
$1.46 -0.01 (-0.68%)
As of: Sep 29, 2026 · 3:58 PM EDT

Enveric Biosciences (ENVB) Total Current Liabilities (2010 - 2026)

Updated

Enveric Biosciences (ENVB) reported Total Current Liabilities of $861,475 for Q2 2026, down 36.8% from $1.36 million a year earlier but up 87.0% from the prior quarter.

Analysis

Enveric Biosciences (ENVB) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Enveric Biosciences posted Total Current Liabilities of $918,400, down 38.4% from FY2024.

  • Total Current Liabilities has declined for three consecutive years, though with a five-year compound annual growth rate of 6.2% (FY2020 to FY2025).
  • By year, Total Current Liabilities came in at $1.49 million in FY2024 (-36.4%), $2.34 million in FY2023 (-41.4%), $4 million in FY2022 (+46.0%) and $2.74 million in FY2021 (+301.8%).
  • Five-year quarterly Total Current Liabilities spans a low of $460,676 in Q1 2026 and a high of $4.93 million in Q2 2023.
  • Year over year, Total Current Liabilities has now declined in each of the last three quarters, with an average decline of 22.9% over the last eight quarters.
  • The high point for year-over-year Total Current Liabilities in five years was Q4 2021 (growth of 301.8%); the low point was Q2 2024 (a decline of 86.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $460,676 (Q1 2026), $918,400 (Q4 2025) and $905,885 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Enveric Biosciences 5.86 Mn -15.78 Mn - 861,475.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 861,475.00
Mar 31, 2026 460,676.00
Dec 31, 2025 918,400.00
Sep 30, 2025 905,885.00
Jun 30, 2025 1.36 Mn
Mar 31, 2025 1.18 Mn
Dec 31, 2024 1.49 Mn
Sep 30, 2024 839,166.00
Jun 30, 2024 645,340.00
Mar 31, 2024 2.37 Mn
Dec 31, 2023 2.34 Mn
Sep 30, 2023 4.18 Mn
Jun 30, 2023 4.93 Mn
Mar 31, 2023 4.44 Mn
Dec 31, 2022 4.00 Mn
Sep 30, 2022 2.60 Mn
Jun 30, 2022 2.32 Mn
Mar 31, 2022 2.09 Mn
Dec 31, 2021 2.74 Mn
Sep 30, 2021 2.16 Mn
API Access

Enveric Biosciences Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ENVB&period=max&api_key=YOUR_API_KEY